NUMBER 2

INTAN MUTIARA LTD

Comparative Financial Data

For Years Ended December 31, 2020, 2019 and 2018

(in Thousands of Rupiah)

December 31st position.

Account/Post

Year 2020

Year 2019

Year 2018

Current Liabilities

    1.300.000

    1.600.000

        4.500.000

Non-Current Liabilities

    9.900.000

    4.500.000

        4.500.000

Paid-in Capital

    5.000.000

    5.000.000

        5.000.000

Retained Earnings

    3.000.000

    4.300.000

        4.300.000

Assets

  19.200.000

  15.400.000

      17.180.000


Question :

You are asked to perform a Profitability/Profitability Ratio analysis on the financial data of INTAN MUTIARA LTD, which consists of:

a. Net Profit Margin (NPM), and provide a review/explanation on the meaning of the results of the calculation of the NPM Ratio.
b. Return On Equity (ROE), and provide a review/explanation on the meaning of the results of the calculation of the ROE Ratio.
c. Return On Investment (ROI), and provide a review/explanation on the meaning of the results of the calculation of the ROI Ratio.

Link of the excel:

Komentar

Posting Komentar

Postingan populer dari blog ini

3

 Do the following questions below correctly, and carefully! III. STATEMENT OF CASH FLOW (30%) The following information is presented below in the Comparative Financial Position Report of PT Mayora Indah Tbk for the 2017 and 2018 periods: PT. Mayora Indah Tbk. Statement of Comparative Financial Position 2018 And 2017 Period Account Name Year 2018 Year 2017 Aset     Cash Rp              181.600 Rp                96.800 Accounts Receivable Rp              185.600 Rp                66.000 Supplies Rp          ...
Baca selengkapnya

2

 Do the following questions below correctly, and carefully! II. INVESTMENT (35%) As of December 31, 2017, PT Pyridam Farma Tbk has investments in ordinary shares which are categorized as long-term investments as follows: Common Stock Investment Number of Ordinary Shares Outstanding Total Cost PT. Indofarma Tbk. 2,000 shares of ordinary shares Rp   70.000.000 PT. Kalbe Farma Tbk. 5,000 shares of ordinary shares Rp 100.000.000 PT. Kimia Farma Tbk. 1,000 shares of ordinary shares Rp   85.000.000 On that date, the fair value or market value of all common shares is equal to cost. The company does not have significant influence over the investee. Transactions that occurred during 2018 are as follows: 1. On June 1 2018 that a cash dividend was received from PT Kalbe Farma Tbk in the amount of Rp 1,000 per share of common stock. 2. On July 1 2018 ...
Baca selengkapnya

Consignment Number 2

 2. Journalize the months of January, February, March required for the following consignment activities, (Consignment profit is determined independently and not independently) On January 6, the consignor sent 150 units of merchandise worth Rp. 200,000,- / unit with the transportation costs borne by the consignor amounting to Rp. 1,000,000.- January 15-25 (during January) consignee sells 100 units February 1 – 28 (during January) consignee sells 25 units Terms: • Consigned goods are sold at a price of Rp. 400,000, -/unit which is paid in the month of purchase at 50% of the selling price and the rest is paid in the following month. • Commission is 5% of billing. • Consignment delivery costs borne by the consignor are Rp. 1,000,000
Baca selengkapnya